CRISPR Therapeutics

CRISPR Therapeutics develops clinical gene-editing therapies using CRISPR-Cas systems. While sharing foundational CRISPR IP with Algen, its emphasis is on therapeutic editing rather than discovery platforms. Companies seeking Algen-style target identification would find CRISPR Therapeutics less relevant for AI-driven causal biology mapping.